Breaking News, Trials & Filings

Trials & Filings in Brief: Jan. 6, 2014

Alkermes, DiaVacs, Kala, Oxygen Biotherpeutics, Peregrine, TauRx

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase III Oxygen posts LCOS trial protocol . . . read more TauRx adds research centers for Alzheimer’s studies . . . read more Filings Alkermes receives MMF patent . . . read more DiaVacs gets orphan status for T1DM immunotherapy . . . read more Kala files IND for post-cataract treatment . . . read more Peregrine gets Fast Track for NSCLC biologic . . . read more...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters